Immunologic abnormalities in the acquired immunodeficiency syndrome.
about
A reflection on HIV/AIDS research after 25 yearsVertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replicationDevelopmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human StudiesRelease of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivoLipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses.Binding site for human immunodeficiency virus coat protein gp120 is located in the NH2-terminal region of T4 (CD4) and requires the intact variable-region-like domain.Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individualsEvidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletiTissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response.The effects of HIV infection on endothelial function.Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.Immune interventions in HIV infection.A report of a successfully treated case of ABPA in an HIV-infected individual.Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndromeDefective postbinding lysis underlies the impaired natural killer activity in factor VIII-treated, human T lymphotropic virus type III seropositive hemophiliacsHuman T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attackDiversity and virulence thresholds in AIDS.Human peripheral blood CD4+ and CD8+ T cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated Brucella abortus.Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy.Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis cariniiBrucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1.Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individualsInfluence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression.Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cellsCytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15.Kaposi's sarcoma and its associated herpesvirus.Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.ts1, a temperature-sensitive mutant of Moloney murine leukemia virus TB, can infect both CD4+ and CD8+ T cells but requires CD4+ T cells in order to cause paralysis and immunodeficiencyPhase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complexAbsence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire.An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cellsIn vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivityInhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1Increased expression of CD4 molecules on Jurkat cells mediated by human immunodeficiency virus tat protein.Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.
P2860
Q21245200-99613806-5F89-4217-9598-2A974A77FEB5Q24628991-63EEA9D1-99C6-44AD-BAEE-805E3465DC65Q28368266-4CFBCBF4-583E-4911-9DC1-DCF13FBEC117Q28390094-9CA3482A-FD6C-47F4-B115-D4913ED66144Q33449190-3A330301-50CF-411A-9458-A6FF43CB010EQ33594975-4059EA8B-5BEC-400F-978D-DA3D88B6AAC4Q33641132-A147D213-99BF-4428-A6A7-3A621E5B3621Q33734957-7E936759-6B0C-4700-98C0-C671F225889BQ33827993-9111695F-7F86-4550-B65B-94031F9BCBAFQ33899991-B4EBC5D1-2F65-4B6F-80FD-B569EC9F9CA6Q34153342-445229E6-419C-45DA-B1AE-5F4CC2924795Q34233791-93117371-7A76-4B62-871D-CD877DD9C76AQ34331118-D5274BC3-CE41-4EB3-B0BE-9F0E86E03C6DQ34351326-A180EFBA-50BE-4368-B909-F7D49F2A4A41Q34476772-49B28A02-C156-45E9-88BB-1BA2D5616120Q34545986-7A3D3C34-45A8-4108-8408-FDBDD6097B27Q34572991-AE7F3B1F-4AF3-4743-A463-C68B8C3195F4Q34636237-3ECD484E-734C-45CC-BA6C-2C553D39CF71Q34983038-8BC3A11C-35FD-47E8-8F64-91452C8CF616Q35424419-0C70216C-B94E-4C87-983C-5093C3F9717BQ35592036-09A103A9-DB74-44C9-BC46-1EFCE1E4E957Q35598327-5E3D4EED-EC1A-4422-9B1A-CA21B15AF975Q35773520-5BCD5103-3F4B-49AD-9AD0-0B68CCB81A63Q35839410-E24EC914-534E-4C1C-9822-AA8A5BB0182FQ35843933-C602E71D-44C9-4363-B91B-70B6806068FCQ35844592-EDC80A8A-3A1F-4928-8D81-E67DC6632D9CQ36351580-A53D5D77-B633-48C5-ADF1-CC1B6321DCC2Q36360966-8483C3FF-58D5-4B09-8E51-FB646412F200Q36365779-894637C1-FF31-42E9-AC49-954A48E64B2AQ36487309-B0CE49DC-8786-46AD-B6B0-84A9103307D8Q36635613-7AAEB0AC-9F8A-4198-B69B-36040B117B83Q36651371-40EDB546-0E36-4E50-830A-2D6D6CF31D75Q36696698-7FE0136F-8AAE-4E96-BCA3-B59836E41040Q36757510-F1230D1C-75C2-4E50-9D7A-5DD6795FE85AQ36799449-436A90E4-4289-420C-8B6F-A77BA41B3EA8Q36803081-F346611C-57EF-473F-B23D-556B3BBB3304Q36825840-9568C744-F9F1-489D-A0F1-3F6331D35738Q36829695-6FF09850-6EF4-40CA-A47C-B9B1EF95538AQ36882588-6B21B5AB-2B3D-45F4-A337-806AC4B6A87DQ36885076-3998ACB1-A643-4283-B83F-31880B2501D8
P2860
Immunologic abnormalities in the acquired immunodeficiency syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immunologic abnormalities in the acquired immunodeficiency syndrome.
@en
type
label
Immunologic abnormalities in the acquired immunodeficiency syndrome.
@en
prefLabel
Immunologic abnormalities in the acquired immunodeficiency syndrome.
@en
P1476
Immunologic abnormalities in the acquired immunodeficiency syndrome.
@en
P304
P356
10.1146/ANNUREV.IY.03.040185.002401
P577
1985-01-01T00:00:00Z